Karty Dormera
Primary Care · West Jordan, UTNPI 1033970322
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations.
Across 75 payments — averaging $19.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$165
- Lilly USA, LLC$133
- AbbVie$125
- Organon$125
- Corcept Therapeutics$107
- Amgen$94
- plus $751 from 23 others
What the payments were for
- Food & beverage$1,499100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 5 | $165 |
| Lilly USA, LLC | 8 | $133 |
| AbbVie | 6 | $125 |
| Organon | 7 | $125 |
| Corcept Therapeutics | 3 | $107 |
| Amgen | 5 | $94 |
| Novo Nordisk | 5 | $83 |
| Axsome Therapeutics, Inc. | 4 | $66 |
| Bayer | 3 | $64 |
| Astellas Pharma US Inc | 3 | $63 |
| Biogen | 3 | $60 |
| Pfizer | 4 | $60 |
| Merck | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Seqirus USA Inc | 1 | $27 |
| Solventum Corporation | 1 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Shield Therapeutics Inc | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Exeltis, USA Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Medtronic | 1 | $15 |
| Exact Sciences | 1 | $15 |
| GSK | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Vertex | 1 | $14 |
| Innovation Technologies Inc | 1 | $14 |
How this compares
$1,499 in reported general payments places this provider in the 75th percentile of 60 primary care providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $816 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $705 |
| Levothyroxine Sodium | 26 | $414 |
| Omeprazole | 13 | $330 |
| Lisinopril | 19 | $325 |
| Cephalexin | 11 | $282 |
| Gabapentin | 16 | $174 |
| Ibuprofen | 16 | $141 |
| Losartan Potassium | 16 | $99 |
| Rosuvastatin Calcium | 11 | $73 |
| Escitalopram Oxalate | 16 | $71 |
| Citalopram HbrCitalopram Hydrobromide | 15 | $57 |
| Pantoprazole Sodium | 11 | $53 |
| Prednisone | 19 | $52 |
| Tramadol Hcl | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other primary care in West Jordan
- Liana KinikiniWest Jordan$4K
- Megan BlissWest Jordan$62
- London JacksonSpringville$22K
- Tyler HobbsProvo$15K
- Jeffrey WalshBountiful$15K
- Marcella RowleyRiverton$13K
- Elizabeth WillmoreRiverton$6K
- Dustin ThompsonLayton$6K
- Catherine CoatesSalt Lake City$5K
- Stacey LakeHolladay$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.